This independent study represents the perspectives of 83 UK-based patient groups on the corporate reputation of 15 individual pharma companies, and of the pharma industry as a whole, during 2017. The opinions of the UK patient groups, which were gathered in a survey conducted November 2017-February 2018, are compared in the report with those from the entire worldwide body of 1,330 patient groups which responded to the annual study, ‘The Corporate Reputation of Pharma - from a Patient Perspective’, and with the UK patient-group responses from the previous year (2016).
The 15 pharma companies reviewed for their corporate reputation in the 2017 study are:
- Boehringer Ingelheim
- Bristol-Myers Squibb
- Eli Lilly (Lilly)
- Merck & Co (MSD in the UK)
The UK corporate-reputation survey is now in its 6th edition - thus, 6 years of historical data are available. In addition, we incorporated several important new indicators of corporate reputation into the 2017 survey—to reflect the changing, and more demanding, relationships that now exist between patient groups and pharma companies.
The UK patient groups responding to the 2017 survey assessed the 15 companies for their excellence at:
- patient centricity;
- the provision of high-quality patient information;
- patient safety;
- the provision of high-quality products;
- transparency (in pricing policies; in sharing the results of clinical data; and in the funding of external stakeholders);
- providing services 'beyond the pill';
- engaging patients (in research and in development)
Patient-Group Relationships With Pharma, 2017
Industry-Wide Findings, 2017
Rankings Of The 15 Pharma Companies, 2017 V. 2016 Among UK Patient Groups Familiar With The Companies
Positionings Of 8 Pharma Companies, 2017 V. 2016 Among UK Patient Groups That Work/Partner With The Companies
Profiles Of The 15 Companies, 2017
I. UK Patient Groups: Views On Pharma; And Recommendations For Improvement
Ii. Profiles Of Respondent UK Patient Groups, 2017
Tables and Charts
The Pharma Industry’S Corporate Reputation, 2012-2017 (According To UK Patient Groups)
Companies Ranking 1St For Each Of The 12 Indicators, 2017 (According To UK Patient Groups
The 12 Indicators Used To Measure Companies’ Corporate Reputation
Levels Of Familiarity Of UK Patient Groups With The 15 Companies, 2017 (And Levels Of Types Of Relationships That UK Patient Groups Have With Pharmaceutical Companies, 2017
The Corporate Reputation Of The Pharmaceutical Industry, 2017 V. 2016—Compared With
The Corporate Reputation Of The Pharmaceutical Industry, 2012-2017, According To UK Patient Groups
Perceptions Of The Efficacy Of The Pharmaceutical Industry At Various Activities Of Importance To UK Patient Groups, 2017 [Chart And Table]
Perceptions Of The Efficacy Of The Pharmaceutical Industries At Various Activities
According To UK Patient Groups 2017 V. 2016 V. Patient Groups Worldwide 2017
UK Patient Groups’ Views On Various Activities Of Pharma (2017), Compared With The Views Of Patient Groups From 18 Other Countries/Regions
Rankings Of Individual Pharma Companies, 2017 V. 2016 (According To UK Patient Groups Familiar With The Company)
Positionings Of Individual Pharma Companies, 2017 V. 2016 (According To UK Patient Groups That Work/Partner With The Company)
Profiles Of The 15 Companies, 2017
Charts And Tables For Each Of The 46 Companies:
Number Of UK Patient Groups Claiming Familiarity With The Company, 2017.
Number Of UK Patient Groups Saying That They Had A Working Relationship With The Company, 2017.
Company Scores Among UK Patient Groups Familiar With The Company, And Which Worked With The Company, For Each Of The 12 Indicators Of Corporate Reputation, 2017.
Percentage Of The UK Patient Groups That Worked With The Company, But Which Also Worked With Other Companies, 2017.
Profile Of Respondent UK Patient Groups Familiar, And Working, With The Company, 2017: Specialties; Geographic Remit; And Types Of Relationships.
The Company Pcris (Patient Corporate Reputation Index) For Each Of The 12 Indicators—As Assessed By UK Companies 2017 V. 2016 V. 2015
Overall Rankings For The Company According To UK Patient Groups Familiar With The Company, 2017.
Overall Positionings For The Company According To UK Patient Groups That Work With The Company, 2017.
Company Rankings For Each Of The 12 Indicators According To UK Patient Groups Familiar, Or Working, With The Company, 2017 V. 2016.
The Company’S Net Promoter Score, 2017—As Assessed By UK Patient Groups Working With The Company.